These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11671050)

  • 1. Retro Models of Pt Anticancer Drug DNA Adducts: Chirality-Controlling Chelate Ligand Restriction of Guanine Dynamic Motion in (2,2'-Bipiperidine)PtG(2) Complexes (G = Guanine Derivative).
    Ano SO; Intini FP; Natile G; Marzilli LG
    Inorg Chem; 1999 Jun; 38(12):2989-2999. PubMed ID: 11671050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing conformer equilibria in retro models of cisplatin-DNA adducts as revealed by moderately dynamic (N,N'-dimethyl-2,3-diaminobutane)PtG(2) retro models (G = a guanine derivative).
    Saad JS; Scarcia T; Natile G; Marzilli LG
    Inorg Chem; 2002 Sep; 41(19):4923-35. PubMed ID: 12230397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chirality-Controlling Chelate (CCC) Ligands in Analogues of Platinum Anticancer Agents. Influence of N9 Substituents of Guanine Derivatives (G) on the Distribution of Chiral Conformers of (CCC)PtG(2) with CCC = N,N'-Dimethyl-2,3-diaminobutane.
    Marzilli LG; Intini FP; Kiser D; Wong HC; Ano SO; Marzilli PA; Natile G
    Inorg Chem; 1998 Dec; 37(26):6898-6905. PubMed ID: 11670827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of second-sphere communication, leading to an unusually high abundance of the head-to-head conformer of cisplatin cross-link retro models.
    Saad JS; Scarcia T; Shinozuka K; Natile G; Marzilli LG
    Inorg Chem; 2002 Feb; 41(3):546-57. PubMed ID: 11825082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts of Guanine Derivatives with the Hybrid Ligand Approach: Evidence for Cis Interligand Interactions Especially between 3'-GMP's.
    Wong HC; Intini FP; Natile G; Marzilli LG
    Inorg Chem; 1999 Mar; 38(5):1006-1014. PubMed ID: 11670875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic coordination chemistry relevant to DNA adducts formed by the cisplatin anticancer drug. NMR studies on compounds with sterically crowded chiral ligands.
    Saad JS; Benedetti M; Natile G; Marzilli LG
    Inorg Chem; 2010 Jun; 49(12):5573-83. PubMed ID: 20496875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin--DNA cross-link models with an unusual type of chirality-neutral chelate amine carrier ligand, N,N dimethylpiperazine (Me2ppz): Me2ppzPt(guanosine monophosphate)2 adducts that exhibit novel properties.
    Sullivan ST; Ciccarese A; Fanizzi FP; Marzilli LG
    Inorg Chem; 2000 Feb; 39(4):836-42. PubMed ID: 11272585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ground-state stability and rotational activation parameters for individual rotamers of (R,S,S,R)-(N,N'-dimethyl-2,3-diaminobutane)PtG(2) complexes (G = 9-EtG, 3'-GMP, and 5'-GMP).
    Colonna G; Di Masi NG; Marzilli LG; Natile G
    Inorg Chem; 2003 Feb; 42(4):997-1005. PubMed ID: 12588131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare example of three abundant conformers in one retro model of the cisplatin-DNA d(GpG) intrastrand cross link. Unambiguous evidence that guanine O6 to carrier amine ligand hydrogen bonding is not important. possible effect of the Lippard base pair step adjacent to the lesion on carrier ligand hydrogen bonding in DNA adducts.
    Sullivan ST; Ciccarese A; Fanizzi FP; Marzilli LG
    J Am Chem Soc; 2001 Sep; 123(38):9345-55. PubMed ID: 11562217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Steric Hindrance Approach Employing the Hybrid Ligand 2-Aminomethylpiperidine for Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts Containing Guanine Derivatives.
    Wong HC; Coogan R; Intini FP; Natile G; Marzilli LG
    Inorg Chem; 1999 Feb; 38(4):777-787. PubMed ID: 11670844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-DNA cross-link retro models with a chirality-neutral carrier ligand: evidence for the importance of "second-sphere communication".
    Sullivan ST; Ciccarese A; Fanizzi FP; Marzilli LG
    Inorg Chem; 2001 Jan; 40(3):455-62. PubMed ID: 11209601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-stranded oligonucleotide adducts formed by Pt complexes favoring left-handed base canting: steric effect of flanking residues and relevance to DNA adducts formed by Pt anticancer drugs.
    Saad JS; Marzilli PA; Intini FP; Natile G; Marzilli LG
    Inorg Chem; 2011 Sep; 50(17):8608-20. PubMed ID: 21819051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR studies of models having the Pt(d(GpG)) 17-membered macrocyclic ring formed in DNA by platinum anticancer drugs: Pt complexes with bulky chiral diamine ligands.
    Saad JS; Benedetti M; Natile G; Marzilli LG
    Inorg Chem; 2011 May; 50(10):4559-71. PubMed ID: 21510625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel binding interactions of the DNA fragment d(pGpG) cross-linked by the antitumor active compound tetrakis(mu-carboxylato)dirhodium(II,II).
    Chifotides HT; Koshlap KM; Pérez LM; Dunbar KR
    J Am Chem Soc; 2003 Sep; 125(35):10714-24. PubMed ID: 12940757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray structural characterization of the bis-guanine derivative of a cisplatin analogue having just one proton on each coordinated nitrogen and a head-to-head conformation: [Pt{(+/-)-N,N'-dimethyl-2,3-diaminobutane}(9-ethyl-guanine)2]dinitrate.
    Intini FP; Cini R; Tamasi G; Hursthouse MB; Marzilli LG; Natile G
    Inorg Chem; 2010 Sep; 49(17):7853-60. PubMed ID: 20799737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum complexes with NH groups on the carrier ligand and with only one guanine or hypoxanthine derivative. Informative models for assessing relative nucleobase and nucleotide hydrogen-bond interactions with amine ligands in solution.
    Carlone M; Marzilli LG; Natile G
    Inorg Chem; 2004 Jan; 43(2):584-92. PubMed ID: 14731020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotamer stability in cis-[Pt(diA)G2] complexes (diA = diamine derivative and G = guanine derivative) mediated by carrier-ligand amine stereochemistry as revealed by circular dichroism spectroscopy.
    Benedetti M; Marzilli LG; Natile G
    Chemistry; 2005 Sep; 11(18):5302-10. PubMed ID: 15997435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neglected bidentate sp2 N-donor carrier ligands with triazine nitrogen lone pairs: platinum complexes retromodeling cisplatin guanine nucleobase adducts.
    Maheshwari V; Marzilli PA; Marzilli LG
    Inorg Chem; 2008 Oct; 47(20):9303-13. PubMed ID: 18800828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of carrier ligand NH hydrogen bonding to the O6 and phosphate group of guanine nucleotides in platinum complexes with a single guanine ligand.
    Carlone M; Fanizzi FP; Intini FP; Margiotta N; Marzilli LG; Natile G
    Inorg Chem; 2000 Feb; 39(4):634-41. PubMed ID: 11272556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
    Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
    J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.